3 publication(s) trouvée(s)
Article scientifique
Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
The legends for Figs. 3 and 5 of the article [1] incorrectly refer to an “all others group”. The corrected …
Article scientifique
Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
The use of imatinib, sunitinib, and regorafenib has transformed the treatment of advanced GIST. Sunitinib and regorafenib improve progression free-survival …
Article scientifique
Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman …